Cargando…
Effectiveness and Costs of Molecular Screening and Treatment for Bacterial Vaginosis to Prevent Preterm Birth: The AuTop Randomized Clinical Trial
IMPORTANCE: Bacterial vaginosis (BV) is a well-known risk factor for preterm birth. Molecular diagnosis of BV is now available. Its impact in the screening and treatment of BV during pregnancy on preterm births has not been evaluated to date. OBJECTIVE: To evaluate the clinical and economic effects...
Autores principales: | Bretelle, Florence, Loubière, Sandrine, Desbriere, Raoul, Loundou, Anderson, Blanc, Julie, Heckenroth, Hélène, Schmitz, Thomas, Benachi, Alexandra, Haddad, Bassam, Mauviel, Franck, Danoy, Xavier, Mares, Pierre, Chenni, Nawal, Ménard, Jean-Pierre, Cocallemen, Jean-François, Slim, Nadia, Sénat, Marie Victoire, Chauleur, Céline, Bohec, Caroline, Kayem, Gilles, Trastour, Cynthia, Bongain, André, Rozenberg, Patrick, Serazin, Valerie, Fenollar, Florence |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Medical Association
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352927/ https://www.ncbi.nlm.nih.gov/pubmed/37459059 http://dx.doi.org/10.1001/jamapediatrics.2023.2250 |
Ejemplares similares
-
Screen-and-treat program by point-of-care of Atopobium vaginae and Gardnerella vaginalis in preventing preterm birth (AuTop trial): study protocol for a randomized controlled trial
por: Bretelle, Florence, et al.
Publicado: (2015) -
Erratum to: ‘Screen-and-treat program by point-of-care of Atopobium vaginae and Gardnerella vaginalis in preventing preterm birth (AuTop trial): study protocol for a randomized controlled trial’
por: Bretelle, Florence, et al.
Publicado: (2016) -
Teaching and performing audits on caesarean delivery reduce the caesarean delivery rate
por: Lesieur, Emmanuelle, et al.
Publicado: (2018) -
Outpatient versus inpatient care for preterm premature rupture of membranes before 34 weeks of gestation
por: Bouchghoul, Hanane, et al.
Publicado: (2019) -
Evaluation of Current and New Biomarkers in Severe Preeclampsia: A Microarray Approach Reveals the VSIG4 Gene as a Potential Blood Biomarker
por: Textoris, Julien, et al.
Publicado: (2013)